Expert-Guided Early Tracheostomy Pathway

Denver Health and Hospital Authority

Status: Completed

Conditions: Respiratory Failure; Tracheostomy Complication

Treatments: Other: Expert-Guided Early Tracheostomy

Study type: Interventional

Funder types: Other

Identifiers

NCT05595707

Trachtime22

Details and patient eligibility

About

The optimal timing of tracheostomy insertion remains uncertain. We hypothesized that a clinical pathway including expert-informed risk assessment regarding predicted duration of mechanical (MV) would enhance the effectiveness of early percutaneous dilatational tracheostomy (PDT) for patients with anticipated prolonged durations of MV, as reflected by duration of ventilation, complications, and patient-centered outcomes.

Full description

three-year prospective observational study (2018-2020) at a tertiary care level 1 trauma center (King Hussein Medical Center) in Amman Jordan and 4 affiliated subspecialty hospitals. The study sequentially enrolled all adult patients (>18yo) with critical illness receiving MV in an intensive care unit for 48 hours or longer. Institutional ethical committee clearance for the study was secured.

Enrollment: 104 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients undergoing continued MV for 48 or more hours for whom continuation of life-prolonging therapy was indicated

Exclusion criteria

Patients at imminent risk of death were included

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

104 participants in 1 patient group

Early Percutaneous dilatational tracheostomy

Experimental group

Description:

PDT reccomended for patients with high risk for prolonged mechanical ventilation.

Treatment:

Other: Expert-Guided Early Tracheostomy